Purpose
The following product summary can be used by product providers to prepare orders for fall and winter virus season.
Presentations and Indications
AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV).
CDC recommends a single dose of RSV vaccines for:
- All adults ages 75 and older
- Adults ages 60-74 who are at increased risk of severe RSV disease
Ordering and Return Policy
Minimum Initial Order
AREXVY is supplied in a 10 pack. The minimum order would be equal to one pack of 10.
Order directly on GSKDirect.
Pre-ordering or Reservation Programs
Pre-ordering or reservation programs are not offered for AREXVY.
Return Policy
Unopened Vaccine
Arexvy return policy is upon expiry date.
Opened Vaccine
Arexvy return policy is upon expiry date.
For additional questions, please go to GSK Help Center.
Diluent Type and Volume
AREXVY is supplied as 2 components: A single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes or needles).
Cap and Label Color (For vials)
AREXVY is supplied in 2 vials that must be reconstituted prior to administration. Vial 1 is an adjuvant suspension component (liquid) with a brown flip cap and gold metal skirt. Vial 2 is a Lyophilized antigen component (powder) in a mustard flip cap and silver (clear) metal skirt.
Doses
| AREXVY | |
|---|---|
| How the vaccine is supplied | Single-dose vials |
| Number of doses per vial | N/A |
| Dosage |
For injectable suspension. AREXVY is supplied as a single-dose vial of lyophilized antigen component to be reconstituted with the accompanying vial of adjuvant suspension component. A single dose after reconstitution is 0.5 mL.
|
| Dose volume | 0.5 mL |
| Reconstitution | Yes |
Shelf Life
| Shelf Life | GSK |
|---|---|
| Unopened, frozen vaccine | Do not freeze. Discard if the vaccine has been frozen. |
| Unopened, refrigerated vaccine | The shelf life may vary based on when the vaccine is received by the end user. Currently AREXVY’s expiry date is approved by the FDA for 36 months from time of manufacturing. |
| Opened, refrigerated vaccine | Administer immediately or store in the refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature [up to 25°C (77°F)] for up to 4 hours prior to use. |
| Opened, room temperature vaccine | Administer immediately or store in the refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature [up to 25°C (77°F)] for up to 4 hours prior to use. |